by rebsamenlab
December 12, 2024

CCDC134 controls TLR biogenesis through the ER-chaperone Gp96

We are thrilled to announce the latest publication of our lab, now published in the Journal […]
0
read more
by rebsamenlab
October 21, 2023

A new inhibitor of pro-inflammatory responses that could be beneficial to SLE patients in the future

We are excited to share our latest work on the identification of a small molecule targeting […]
0
read more